Advertisement
Screener

WEST PHARMACEUTICAL SERVICES, INC. (WST) Other Income Tax Expense (Benefit), Continuing Operations

2.3 / 5 stars · 56/120 Roast Me

WEST PHARMACEUTICAL SERVICES, INC. Other Income Tax Expense (Benefit), Continuing Operations

WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Other Income Tax Expense (Benefit), Continuing Operations of -$300.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-24.

Discontinued › Expense Statement › Income Tax

us-gaap:OtherIncomeTaxExpenseBenefitContinuingOperations · last filed 2020-02-24

  • WEST PHARMACEUTICAL SERVICES, INC. other income tax expense (benefit), continuing operations for the quarter ending 2019-12-31 was $700.00K.
  • WEST PHARMACEUTICAL SERVICES, INC. other income tax expense (benefit), continuing operations for the quarter ending 2019-09-30 was -$1.00M.
  • WEST PHARMACEUTICAL SERVICES, INC. other income tax expense (benefit), continuing operations for fiscal 2019 was -$300.00K.
Period endOther Income Tax Expense (Benefit), Continuing Operations 3 monthOther Income Tax Expense (Benefit), Continuing Operations 6 monthOther Income Tax Expense (Benefit), Continuing Operations 9 monthOther Income Tax Expense (Benefit), Continuing Operations 12 month
2019-12-31$700.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24
-$300.00K
derived: sum of 2 quarters · filed 2020-02-24
-$300.00K
10-K · filed 2020-02-24
2019-09-30-$1.00M
10-Q · filed 2019-10-29
-$1.00M
10-Q · filed 2019-10-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
DEXCOM INC (DXCM)United States$33.004B25.42
Solventum Corp (SOLV)United States$15.085B9.16
Penumbra Inc (PEN)United States$12.596B77.33
BAXTER INTERNATIONAL INC (BAX)United States$12.139B-10.35
GLOBUS MEDICAL INC (GMED)United States$9.977B20.03
INSULET CORP (PODD)United States$9.420B28.12
GLAUKOS Corp (GKOS)United States$9.135B-43.73
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
TELEFLEX INC (TFX)United States$5.093B-5.44